Suppliers and packagers for MILRINONE LACTATE IN DEXTROSE 5%

MILRINONE LACTATE IN DEXTROSE 5%

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Caplin	MILRINONE LACTATE IN DEXTROSE 5%	milrinone lactate	INJECTABLE;INJECTION	219170	ANDA	Caplin Steriles Limited	65145-176-10	10 POUCH in 1 CASE (65145-176-10) / 1 BAG in 1 POUCH (65145-176-01) / 100 mL in 1 BAG	2026-06-25
Caplin	MILRINONE LACTATE IN DEXTROSE 5%	milrinone lactate	INJECTABLE;INJECTION	219170	ANDA	Caplin Steriles Limited	65145-177-10	10 POUCH in 1 CASE (65145-177-10) / 1 BAG in 1 POUCH (65145-177-01) / 200 mL in 1 BAG	2026-06-25
Caplin	MILRINONE LACTATE IN DEXTROSE 5%	milrinone lactate	INJECTABLE;INJECTION	219170	ANDA	Somerset Therapeutics, LLC	70069-872-10	10 POUCH in 1 CASE (70069-872-10) / 1 BAG in 1 POUCH (70069-872-01) / 100 mL in 1 BAG	2026-03-25
Caplin	MILRINONE LACTATE IN DEXTROSE 5%	milrinone lactate	INJECTABLE;INJECTION	219170	ANDA	Somerset Therapeutics, LLC	70069-873-10	10 POUCH in 1 CASE (70069-873-10) / 1 BAG in 1 POUCH (70069-873-01) / 200 mL in 1 BAG	2026-03-25

Suppliers and packagers for MILRINONE LACTATE IN DEXTROSE 5%

Last updated: June 2, 2026

Milrinone Lactate in Dextrose 5% (MILRINONE D5W): Supplier Landscape, Qualified Manufacturers, and Procurement Sources

Executive summary: Suppliers of milrinone lactate in dextrose 5% (D5W) for intravenous infusion are typically limited to (1) sterile liquid admixture providers that prepare patient-specific infusions under pharmacy outsourcing models and (2) FDA-registered manufacturers producing a milrinone lactate concentrate that is then diluted into D5W by hospital pharmacies or licensed outsourcing facilities. Direct “ready-to-infuse milrinone lactate in D5W” availability is inconsistent across geographies and supply contracts because many products ship as concentrated drug that requires dilution.

Because supply depends on exact concentration (mg/mL), vial size, intended final strength (mg/ mL) in the bag, and container type (100 mL, 250 mL, 500 mL bags), a defensible supplier map requires the specific marketed NDC(s) and site-level sterile manufacturing listings.

Insufficient information to produce a complete and accurate supplier list.